Degarelix Reduces Testosterone Fast Without Initial Hormone Surge

[Guest guest]

More than 95 % of men who took degarelix for prostate cancer saw their

testosterone levels fall dramatically as early as three days after they

started treatment, according to a paper in the December issue of BJU International.

They also experienced much greater falls in their prostate-specific

antigen (PSA) levels at 14 and 28 days than men taking leuprolide.

Researchers from Canada, the USA, France, Denmark and the Netherlands

studied 610 men as part of the Phase Three trial, randomly assigning

them to one of three study groups.Click on the below link for the full story:<http://www.medicalnewstoday.com/articles/132282.php>